NCT07463248 2026-03-11
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
West China Hospital
Phase 2 Not yet recruiting
Clinical Trials
17 trialsNCT07042438 2026-03-05
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
City of Hope Medical Center
Phase 2 Recruiting
NCT07432984 2026-02-25
FMT-LUNG
Samsung Medical Center
Phase 2 Not yet recruiting
NCT06026371 2026-01-12
Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation
Fred Hutchinson Cancer Center
Phase 2 Active not recruiting
NCT04729322 2025-12-23
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06218602 2025-12-16
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05690048 2025-08-06
FLORA
University Hospital Heidelberg
Phase 2 Recruiting
NCT05286294 2025-07-03
MITRIC
Oslo University Hospital
Phase 2 Active not recruiting
NCT06403111 2024-12-20
FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
Changzhou No.2 People's Hospital
Phase 2 Recruiting
NCT03341143 2024-10-30
Fecal Microbiota Transplant (FMT) in Melanoma Patients
University of Pittsburgh
Phase 2 Completed
NCT04951583 2024-08-07
FMT-LUMINATE
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2 Active not recruiting
NCT03678493 2024-05-16
A Study of FMT in Patients With AML Allo HSCT in Recipients
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT03812705 2024-04-23
FEMITGIGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Completed
NCT05502913 2023-10-02
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Soroka University Medical Center
Phase 2 Recruiting
NCT05279677 2022-08-23
FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
ChineseAMS
Phase 2 Unknown
NCT04116775 2022-06-23
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
Phase 2 Unknown
NCT02433483 2017-11-01
Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients
St. Jude Children's Research Hospital
Phase 2 Terminated